AGC Biologics and Quell to progress Treg cell therapy development
AGC Biologics has collaborated with biotechnology company Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy drug …
Post
-
-
Are regulators keeping pace with AI adoption in clinical trials?
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients …
-
Pathos AI raises $365m for oncology drug development
Pathos AI has raised $365m in a Series D funding round as it prepares to widen its AI-enabled platform to …
-
FDA awards cancer drug approvals to AbbVie and MSD
The US Food and Drug Administration (FDA) has approved two oncology drugs: MSD’s Welireg (belzutifan) and AbbVie’s Emrelis (telisotuzumab vedotin-tllv). …
-
Green chemistry: Navigating growing ESG challenges in pharma manufacturing
The pharmaceutical industry is under increasing pressure to transform its manufacturing practices. Traditional processes, often reliant on vast quantities of …
-
Green chemistry: Navigating growing ESG challenges in pharma manufacturing
The pharmaceutical industry is under increasing pressure to transform its manufacturing practices. Traditional processes, often reliant on vast quantities of …
-
FDA awards BioCryst’s Orladeyo NDA for paediatric HAE
The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals’ new drug application (NDA) for Orladeyo (berotralstat), granting it …
-
Introducing the Pharmaceutical Technology Excellence Awards 2025
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to …
-
Podcast: AI and Supervised Machine Learning in Clinical Trials – Ep1
AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta …
-
Sanofi commits ‘at least $20bn’ to US manufacturing through 2030
Sanofi has become the latest big pharma company to boost manufacturing in the US with a hefty investment as the …
-
Engineering the future: how robotics and automation are transforming pharmaceutical logistics
Maintaining efficiency across the supply chain is essential to ensure potentially life-saving pharmaceutical products reach the patients who need them. …
-
AbbVie expands siRNA push with $335m ADARx deal
AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to access its small interfering …
-
Kaerus gains FDA designations for Fragile X syndrome treatment
UK-based Kaerus Bioscience has received US Food and Drug Administration’s (FDA) rare paediatric drug and orphan drug designations for its …
-
Oligonucleotides: The Scottish research hub accelerating production scale up
Oligonucleotides (oligos) are short strands of synthetic DNA or RNA that offer huge potential in treatments for a wide range …
-
Boehringer partners Tempus AI to enhance cancer therapy pipeline
Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer therapy pipeline. The collaboration builds upon previous …
